4-[3-(4-Methylphenyl)-5-ethyl-5-methyl-4-oxo-2-thioxoimidazolidin-1-yl]-2-trifluoromethylbenzonitrile

ID: ALA1086363

PubChem CID: 46889903

Max Phase: Preclinical

Molecular Formula: C21H18F3N3OS

Molecular Weight: 417.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCC1(C)C(=O)N(c2ccc(C)cc2)C(=S)N1c1ccc(C#N)c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C21H18F3N3OS/c1-4-20(3)18(28)26(15-8-5-13(2)6-9-15)19(29)27(20)16-10-7-14(12-25)17(11-16)21(22,23)24/h5-11H,4H2,1-3H3

Standard InChI Key:  SIPHQNDZYLBGMW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -2.8346  -12.8158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8357  -13.6431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1210  -14.0560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4046  -13.6426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4074  -12.8122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1228  -12.4031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5503  -12.3977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2647  -11.9854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5505  -14.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2646  -13.6420    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5512  -14.8799    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7634  -13.2580    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7370  -14.1196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7297  -14.9445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0572  -15.1925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5362  -14.5209    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0453  -13.8578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2933  -13.0711    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.3600  -14.5119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7799  -15.2242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6048  -15.2157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0109  -14.4957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5859  -13.7827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7624  -13.7946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8359  -14.4858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3190  -15.9748    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5582  -14.9407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7375  -15.7657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3208  -16.3490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  8  3  0
  1  7  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
  4 13  1  0
 17 18  2  0
 16 19  1  0
  2  9  1  0
  4  5  1  0
 19 20  2  0
  9 10  1  0
 20 21  1  0
  2  3  1  0
 21 22  2  0
  9 11  1  0
 22 23  1  0
  5  6  2  0
 23 24  2  0
 24 19  1  0
  9 12  1  0
 22 25  1  0
 13 14  1  0
 15 26  2  0
  6  1  1  0
 14 27  1  0
  1  2  2  0
 14 28  1  0
  3  4  2  0
 28 29  1  0
M  END

Associated Targets(non-human)

Ar Androgen Receptor (5522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.46Molecular Weight (Monoisotopic): 417.1123AlogP: 5.19#Rotatable Bonds: 3
Polar Surface Area: 47.34Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.97CX LogD: 5.97
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.64Np Likeness Score: -1.16

References

1. Jung ME, Ouk S, Yoo D, Sawyers CL, Chen C, Tran C, Wongvipat J..  (2010)  Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC).,  53  (7): [PMID:20218717] [10.1021/jm901488g]

Source